These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3370267)

  • 21. Dexamethasone suppression test as an aid for selection of specific antidepressant drugs in patients with endogenous depression.
    Rihmer Z; Arató M; György S; Révai K; Demeter E
    Pharmacopsychiatry; 1985 Sep; 18(5):306-8. PubMed ID: 4048265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and the relationships between post-dexamethasone cortisol and ACTH levels.
    Maes M; Minner B; Suy E
    J Affect Disord; 1989; 17(1):39-46. PubMed ID: 2544636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent cortisol non-suppression after clinical recovery predicts symptomatic relapse in unipolar depression.
    Charles GA; Schittecatte M; Rush AJ; Panzer M; Wilmotte J
    J Affect Disord; 1989; 17(3):271-8. PubMed ID: 2529296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortisol suppression and circadian rhythm in endogenous depression: a preliminary report.
    Lee MA; Taylor MA
    Biol Psychiatry; 1983 Oct; 18(10):1127-32. PubMed ID: 6652153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dexamethasone suppression test and mood response to methylphenidate in primary depression.
    Brown P; Brawley P
    Am J Psychiatry; 1983 Aug; 140(8):990-3. PubMed ID: 6346911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
    Guthrie SK; Vartanian L; Grunhaus L; Hariharan M; Pande A; Haskett RF
    Acta Psychiatr Scand; 1990 Dec; 82(6):427-32. PubMed ID: 2291411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normalisation of the dexamethasone suppression test: a correlate of clinical improvement in primary depressives.
    Bowie PC; Beaini AY
    Br J Psychiatry; 1985 Jul; 147():30-5. PubMed ID: 4063596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone suppression test in depression and other psychiatric illness.
    Coppen A; Abou-Saleh M; Milln P; Metcalfe M; Harwood J; Bailey J
    Br J Psychiatry; 1983 May; 142():498-504. PubMed ID: 6409195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary-adrenal disinhibition in depression: marker of a subtype with characteristic clinical features and response to treatment?
    Brown WA; Qualls CB
    Psychiatry Res; 1981 Apr; 4(2):115-28. PubMed ID: 6939003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the cortisol suppression index and the dexamethasone suppression test.
    Laux G; Schlesser MA; Rush AJ; Orsulak P; Weissenburger J
    J Clin Psychiatry; 1984 Oct; 45(10):431-2. PubMed ID: 6480568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.
    Nelson WH; Orr WW; Stevenson JM; Shane SR
    Arch Gen Psychiatry; 1982 Sep; 39(9):1033-6. PubMed ID: 7115012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of high plasma dexamethasone levels on DST sensitivity: dose-response study in depressed patients and controls.
    Hunt GE; O'Sullivan BT; Johnson GF; Caterson ID
    Psychiatry Res; 1991 Feb; 36(2):209-22. PubMed ID: 2017535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone suppression test and MMPI scales.
    Ansseau M; von Frenckell R; Franck G; Geenen V; Legros JJ
    Neuropsychobiology; 1986; 16(2-3):68-71. PubMed ID: 3587578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dexamethasone test: suppressors and non-suppressors, what's the difference?].
    Vandel S; Bonin B; Vandel B; Allers G; Volmat R
    Encephale; 1985; 11(4):157-62. PubMed ID: 2935387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The predictive value of the dexamethasone suppression test. A placebo-controlled study.
    Peselow ED; Stanley M; Filippi AM; Barouche F; Goodnick P; Fieve RR
    Br J Psychiatry; 1989 Nov; 155():667-72. PubMed ID: 2532946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine aspects of primary endogenous depression: VI. Receiver operating characteristic analysis of the cortisol suppression index versus the dexamethasone suppression test in patients and matched controls.
    McCracken JT; Rubin RT; Poland RE
    Psychiatry Res; 1988 Oct; 26(1):69-78. PubMed ID: 3237907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DST results in nonpsychotic depressed outpatients.
    Khan A; Johnson F; Avery DH; Cohen S; Scherzo B; Dunner DL
    Am J Psychiatry; 1988 Sep; 145(9):1153-6. PubMed ID: 3046385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma dexamethasone levels in children given the dexamethasone suppression test.
    Naylor MW; Greden JF; Alessi NE
    Biol Psychiatry; 1990 Mar; 27(6):592-600. PubMed ID: 2322618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dexamethasone suppression test and response to antidepressant therapy in psychogeriatric patients.
    Shrimankar J; Soni SD; Sampath G
    Acta Psychiatr Scand; 1988 Jun; 77(6):712-8. PubMed ID: 3407439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.